The relationship between the exon 10 of the p47phox polymorphism and stroke and the effect of the polymorphism on plasma lipid

Chinese Journal of Medical Genetics

Volumn 24, Issue 5, 2007, Pages 524-528

  Huang, Xiao Song ^a   Yang, Qi Dong ^a   Guo, Ttan Sheng ^a   Long, Xian Yu ^a   Yang, Jie ^a   Tang, Qing Ping ^a   Sheng, Xiang Ming ^a   Zhu, Xiao Yan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Genetic polymorphism; p47phox gene; Plasma lipid; Stroke

Indexed keywords

OXIDOREDUCTASE; PROTEIN P47; PROTEIN P47PHOX; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN INFARCTION; CHINESE; CONTROLLED STUDY; EXON; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PEDIGREE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; ETHNIC GROUPS; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; NADPH OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; STROKE;

EID: 35348956513     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cifuentes ME, Pagano PJ. Targeting reactive oxygen species in hypertension. Curr Opin Nephrol Hypertens, 2006, 15:179-186.
2. Calkin AC, Cooper ME, Jandeleit-Dahm KA, et al. Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia, 2006, 49:766-774.
3. Shukla N, Koupparis A, Jones RA, et al. Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit. Eur J Pharmacol, 2006, 531:201-208.
4. Stephen J, Chanock JR, Shixing Z, et al. Genomic structure of the human p47-phox (NCF1) gene. Blood Cells Molec Dis, 2000, 26:1537-1546.
5. Wang XD. The highlight diagnosis of cerebrovascular diseases. Chin J Neurol, 1996, 29:379-380.
6. Catto, AJ. Genetic aspect of the hemostatic system in cerebrovascular disease. Neurology, 2001, 57:24-30.
7. Lomax K, Leto T, Nunoi H, et al. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science, 1989, 245:409-412.
8. Ryu T, Hideki S. Molecular mechanism for activation of superoxide-producing NADPH oxidase. Mol Cells, 2003, 16:271-277.
9. phox is involved in redox-mediated gene expression. Free Radical Bio Med, 2002, 32:1116-1122.
10. Cai H, Li Z, Dikalov S, et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem, 2002, 277:48311-48317.
11. phox) polymorphism determines oxidative burst and the severity of arthritis in rats and mice. Cellular Immunol, 2005, 233:97-101.
12. Jialas I, Devarj S. The role of oxidized low density lipoprotein in atherosclerosis. J Nutr, 1996, 26:1051-1057.
13. Motoshima H, Wu X, Mahadev K, et al. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun, 2004, 315:264-271.
14. Zhang C, Yang J, Jacobs JD, et al. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. Am J Physiol Heart Circ Physiol, 2003, 285:2563-2572.
15. Azumi H, Inoue N, Ohashi Y, et al. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol, 2002, 22:1838-1844.
16. Kalinina N, Agrotis E, Tarark Y, et al. Cytochrome b558-dependent NAD (P)H oxidase-phox units in smooth muscle and marcrophages of atherosclerotic. Arterioscler Thromb Vasc Biol, 2002, 22:2037-2043.
17. Oliveira HC, Cosso RG, Alberici LC, et al, Oxidative stress in atherosclerosis prone mouse is due to low antioxidant capacity of mitochondria. J FASEB, 2005, 19:278-280.